Rush MD Anderson Cancer Center at Rush Oak Park
Clinical research site in Oak Park, Illinois · RUSH MD Anderson Cancer Center at Oak Park, 610 S Maple Ave Suite 5400, Oak Park, IL 60304 · (312) 226-2371 · Website
Part of MD Anderson Cancer Center
As of July 2026, 12 paid clinical trials are recruiting at Rush MD Anderson Cancer Center at Rush Oak Park in Oak Park, Illinois. Active studies at this site cover conditions such as Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 and Breast Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Rush MD Anderson Cancer Center at Rush Oak Park (12)
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
E-Mindfulness Approaches for Living After Breast Cancer
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
More research sites in Oak Park
- Illinois Retina Associates (5 trials)
- Illinois Retina Associates, S.C. (2 trials)
- Adverum Clinical (1 trial)
- Illinois Retina Associates SC - Oak Park Site (1 trial)
- Illinois Retina Associates SC Oak Park Site (1 trial)
- Illinois Retina Associates, S.C. - Oak Park (01061) (1 trial)
- Rush Oak Park Hospital (1 trial)
Explore more
Paid clinical trials in Oak Park, IL · Illinois clinical trials